ContraVir Pharmaceuticals, Inc. (CTRV) |
|---|
| $0.81 52 Week Low | $0.84 2017-04-28 15:17:21 MDT | $2.65 52 Week High |
| Healthcare Sector | Biotechnology Industry |
| Nasdaq Stock Exchange | United States Country |
| Market Cap: | $75,170,000 | Micro Cap (Less than $200M) |
| Analyst Recommendation: | 2 | Analysts say: Buy. (1=Strong Buy, 5=Strong Sell) |
| Beta: | 1.53 | Higher Volatility Stock (beta over 1). Stock will go up more when the market goes up, and go down more when the market goes down. Beta of 1 means stock would match the S&P 500 Index. |
ForwardPE: Unknown | 5 Yr Est Growth: Unknown | Yield: 0.00% |
PEG-Y Ratio: N/A | Unknown PEG-Y ratio |
% Above 50 DayMA: -46.50% | % Above 200 DayMA: -49.09% |
CTRV Performance 52 Weeks: 25.89% | S&P 500 Performance 52 Weeks: 13.50% |
Downtrend is still intact: CTRV is below both 50 and 200 day Moving Averages. Currently beyond technical death cross because 50 Day MA is below 200 Day MA. Stock is closer to 52 Week Low than 52 Week High. | CTRV outperforming S&P 500 by 12.39% the last 52 Weeks. |
Price To Book: N/A | Unknown Price to Book Ratio |
EV to EBITDA: -3.92 | Unknown EV to EBITDA ratio |
| Field | Value | Average | Comments |
|---|---|---|---|
| % Held By Insiders | 17.74% | 17.28% | Held by greater than average Insiders. Insiders can sway stock price. Watch insider buying and selling. |
| % Held By Institutions | 2.70% | 62.07% | Institutional percentage lower than average. Institutions may not have conviction in stock. Or is this a chance for institutions to invest more and boost price? |
| Short % Of Float | 5.18% | 07.02% | Shorted percentage less than average percent. Is stock loved? Do traders and investors believe in the stock? |
| Debt to Equity | N/A | 1.08 | Unknown. |
| Profit Margin % | N/A | -00.18% | Unknown. |
| Operating Margin % | N/A | -05.28% | Unknown. |
| Return on Equity % | -4.00% | -08.79% | Return on Equity greater than average percent. Good. |
| Return on Assets % | -144.44% | -01.29% | Return on Assets less than average percent. Stock can do better than this? |
| Revenue Per Employee | $N/A | $883,096.70 | Unknown. |
| Price to Cash | 8.40 | 5.52 | Higher than average Price to Cash. Meaning that the company has a lower percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money. |
| CPEGY Ratio | N/A | 2.26 | Unknown. |
PROS:
| CONS:
|